Annora Pharma Recalls Seizure Drug Due to Potential Mix-Up with Blood Pressure Medication
Annora Pharma has voluntarily recalled over 31,000 bottles of its 100mg Lacosamide seizure medication. The recall stems from a potential mix-up where bottles might contain Selexipag, a high blood pressure drug. The FDA classified this as a Class II recall, indicating a low likelihood of serious health consequences but potential for temporary adverse effects.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.